PRPO

Precipio, Inc.

PRPO A | $6.705 0.07% 210

(0.0% 1d) (7.4% 1m) (897.9% 1y) (0.0% 2d) (0.0% 3d) (0.8% 7d) (-50.7% volume)
Earnings Calendar: 2022-11-10
Market Cap: $ 9,590,108
http://www.precipiodx.com
Sec Filling | Patents | 51 employees

(US) Precipio, Inc. is a cancer diagnostics company, which engages in the development and provision of a platform designed to eradicate the problem of misdiagnosis. Its products include MX-ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HRM kits and ICP liquid biopsy testing. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.

cancer t-cell diagnostics ceiling

add to watch list Paper trade email alert is off

Press-releases

Precipio Announces Year end 2023 Shareholder Update Call
Published: 2024-03-25 (Crawled : 21:00) - globenewswire.com
PRPO A | $6.705 0.07% 210

Health Technology

| 11.83% | O: 0.0% H: 1.4% C: 1.4%
year update

Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY
Published: 2024-02-13 (Crawled : 15:00) - globenewswire.com
PRPO A | $6.705 0.07% 210

Health Technology

| 4.52% | O: 0.47% H: 4.96% C: 0.0%
fy-2023 report

Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer
Published: 2024-02-06 (Crawled : 15:00) - globenewswire.com
PRPO A | $6.705 0.07% 210

Health Technology

| 8.4% | O: -5.98% H: 24.57% C: 15.12%
hemescreen health distribution cancer agreement molecular

Precipio’s Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter
Published: 2024-01-23 (Crawled : 15:00) - globenewswire.com
PRPO A | $6.705 0.07% 210

Health Technology

| 3.87% | O: -4.02% H: 5.48% C: 5.48%

Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan
Published: 2024-01-17 (Crawled : 15:30) - globenewswire.com
PRPO A | $6.705 0.07% 210

Health Technology

| 27.32% | O: -1.33% H: 22.88% C: 16.92%
cell japan distribution agreement

Precipio Announces Christina Valauri joins the Board of Directors
Published: 2024-01-02 (Crawled : 14:00) - globenewswire.com
PRPO A | $6.705 0.07% 210

Health Technology

| 3.23% | O: 0.15% H: 0.0% C: 0.0%

Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024
Published: 2023-12-14 (Crawled : 21:00) - globenewswire.com
PRPO A | $6.705 0.07% 210

Health Technology

| 0.0% | O: -0.07% H: 0.0% C: -0.37%
management

Precipio Announces Q3-2023 Shareholder Update Call
Published: 2023-11-16 (Crawled : 22:00) - globenewswire.com
PRPO A | $6.705 0.07% 210

Health Technology

| -12.87% | O: -5.21% H: 6.59% C: -2.67%
update

Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022
Published: 2023-10-18 (Crawled : 13:00) - globenewswire.com
PRPO A | $6.705 0.07% 210

Health Technology

| 3.71% | O: 2.16% H: 1.98% C: 1.06%
report

Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-202228% Revenue Increase Is Major Step Toward Company Breakeven
Published: 2023-10-18 (Crawled : 14:30) - biospace.com/
PRPO A | $6.705 0.07% 210

Health Technology

| 3.71% | O: 2.16% H: 1.98% C: 1.06%
company report

See all

Last 15 days Sec forms

File Id	Form	Published Date	Transaction Date	Direction	Code	Amount Transacted	Owned Amount
0001104659-24-048332	4	2024-04-17	2024-04-15	Buy	A	9693	10071
0001104659-24-048330	4	2024-04-17	2024-04-15	Buy	A	5913	16033
0001104659-24-048328	4	2024-04-17	2024-04-15	Buy	A	8143	8461